Ophthalmology Devices Market Size, Share, Growth Analysis, By Product(Surgical & Vision Care), By Application(Cataract and Glaucoma), By End-user(Hospitals, Ophthalmic Clinics, Eye Clinics and Others), By Region - Industry Forecast 2024-2031

North America controlled 43% of the market by 2022. The major factors influencing the market were the continuous expansion of the aging population and chronic eye problems due to high stress and lifestyle. The negative course of diabetic retinopathy is common. The ophthalmic device market in this region is expected to be driven by additional reimbursements for ophthalmology treatments and stringent regulations designed to ensure patient safety. North America, especially the United States, holds a dominant position in the global market. The industry benefits from well-established healthcare infrastructure, higher healthcare costs and a higher patient population with various eye diseases.

The Asia-Pacific is predicted to grow at the fastest CAGR throughout the forecast period owing to rapidly developing medical systems, increasing incidence of eye diseases such as glaucoma and high patient awareness consequently. The Asia-Pacific region in the market is growing rapidly, driven by factors such as rising healthcare costs, expanding healthcare coverage and rising incidence of eye diseases due to aging population and lifestyle changes. Asia-Pacific has a large and rapidly growing population, dominated by older people. The aging population in countries such as China, Japan and South Korea contributes to a high incidence of age-related eye diseases such as glaucoma, cataracts and cataracts, and drives the demand for eyewear.